Beacon Biosignals
BOSTON, MA · Founded 2019 · CIK 0001765647 · Medtech · Private
AI-driven software platform that analyzes brain signals (EEG/electrophysiology data) to detect neurological disorders and support clinical decision-making
beaconbiosignals.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $133M
- 3 Form D · Apr 2026
- 6 months since last filing
- Contracts
- $641K
- 1 award · Defense
- #366 of 4531 in medtech
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $50,000 | |
| Private capital raised | Form D · SEC | $29,850,019 | |
| Federal contract | Department of Defense · 430 Each Dreem 3B Headbands With Support | $640,700 | |
| Private capital raised | Form D · SEC | $103,280,711 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 363 | Potsdam Sensors LLC | $647K | — |
| 364 | X-BIOMEDICAL INC | $646K | $425K |
| 365 | Starr Life Sciences Corp. | $642K | $4.1M |
| 366 | Beacon Biosignals | $641K | $133M |
| 367 | Medigus | $623K | $8.6M |
| 368 | Sentien Biotechnologies, Inc. | $610K | $1.0M |
| 369 | PGXL TECHNOLOGIES LLC | $606K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jacob DonoghueDirector · Executive Officer · Promoter
- Jacob Donoghue, M.D., Ph.D.Director · Executive Officer
- Caitlin DonovanDirector
- Pavel RaifeldDirector
- Naveen RaoDirector
- Jarrett RevelsExecutive Officer · Promoter
Patents
- System And A Method For Detecting And Quantifying Electroencephalographic Biomarkers In Alzheimer's Diseaseapplication
- Systems And Methods For Rapid Neurological Assessment Of Clinical Trial Patientsapplication
- Systems And Methods For Measuring Neurotoxicity In A Subjectapplication
- System And A Method For Detecting And Quantifying Electroencephalographic Biomarkers In Alzheimer's Diseaseapplication
- Systems And Methods For Measuring Neurotoxicity In A Subjectapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.